Jones Financial Companies
MRVI icon

Jones Financial Companies’s Maravai LifeSciences MRVI Stock Holding History

Jones Financial Companies’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23K Buy
8,026
+1,000
+14% +$3.39K ﹤0.01% 3242
2025
Q4 		$22.8K Buy
7,026
+2,489
+55% +$8.38K ﹤0.01% 2876
2025
Q3 		$12.8K Hold
4,537
– – ﹤0.01% 2988
2025
Q2 		$11.2K Buy
4,537
+500
+12% +$1.05K ﹤0.01% 2827
2025
Q1 		$9.53K Buy
4,037
+4,026
+36,600% +$15.9K ﹤0.01% 2730
2024
Q4 		$60 Hold
11
– – ﹤0.01% 3375
2024
Q3 		$93 Buy
+11
New +$95 ﹤0.01% 2975
2023
Q4 		– Sell
-35
Closed -$350 – 1024
2023
Q3 		$350 Buy
+35
New +$384 ﹤0.01% 677
2022
Q3 		– Sell
-29
Closed -$1K – 662
2022
Q2 		$1K Sell
29
-35
-55% -$1.11K ﹤0.01% 661
2022
Q1 		$2K Buy
+64
New +$2.15K ﹤0.01% 649

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jones Financial Companies's MRVI Position: Q1 2026 in Review

Jones Financial Companies increased its Maravai LifeSciences (MRVI) stake by 14% in Q1 2026, buying an estimated $3.39K and bringing the position to 8,026 shares worth $23K. The position accounts for ﹤0.01% of the portfolio, ranked #3242.

Jones Financial Companies first reported a position in MRVI in Q1 2022 and has held it in 10 quarters since. 158 funds tracked by Wall St. Rank hold MRVI as of Q1 2026.

  • Jones Financial Companies held 8,026 shares of Maravai LifeSciences worth $23K as of Q1 2026.
  • Jones Financial Companies bought 1,000 Maravai LifeSciences shares in Q1 2026, an estimated $3.39K.
  • Maravai LifeSciences made up ﹤0.01% of Jones Financial Companies's portfolio in Q1 2026, its #3242 holding.
  • Jones Financial Companies first reported a position in Maravai LifeSciences in Q1 2022 and has held it in 10 quarters since.
  • 158 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2026.

Based on Jones Financial Companies's 13F filing for Q1 2026, filed 15 May 2026.